We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$190M
AUM Growth
Cap. Flow
+$184M
Cap. Flow %
97%
Top 10 Hldgs %
17.3%
Holding
278
New
278
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$3.89M
2
T icon
AT&T
T
+$3.66M
3
CVS icon
CVS Health
CVS
+$3.54M
4
ACN icon
Accenture
ACN
+$3.24M
5
CRM icon
Salesforce
CRM
+$3.04M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Healthcare 17.6%
3 Industrials 10.85%
4 Consumer Discretionary 10.48%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAF icon
26
First American
FAF
$7.58B
$1.47M 0.77%
+25,728
New +$1.45M
MKC icon
27
McCormick & Company Non-Voting
MKC
$14.2B
$1.39M 0.73%
+15,951
New +$1.41M
LSI
28
DELISTED
Life Storage, Inc.
LSI
$1.22M 0.64%
+9,201
New +$1.22M
MSCI icon
29
MSCI
MSCI
$40.9B
$1.21M 0.64%
+2,580
New +$1.26M
DELL icon
30
Dell
DELL
$293B
$1.21M 0.64%
+22,323
New +$1.03M
HSY icon
31
Hershey
HSY
$36.6B
$1.2M 0.63%
+4,809
New +$1.26M
XEL icon
32
Xcel Energy
XEL
$48.8B
$1.2M 0.63%
+19,317
New +$1.29M
HPQ icon
33
HP
HPQ
$27.5B
$1.2M 0.63%
+39,081
New +$1.17M
AAL icon
34
American Airlines Group
AAL
$10.6B
$1.2M 0.63%
+66,759
New +$979K
MU icon
35
Micron Technology
MU
$991B
$1.2M 0.63%
+18,990
New +$1.22M
RPRX icon
36
Royalty Pharma
RPRX
$25.3B
$1.2M 0.63%
+38,961
New +$1.32M
SRE icon
37
Sempra
SRE
$54.8B
$1.2M 0.63%
+16,464
New +$1.24M
TOL icon
38
Toll Brothers
TOL
$14.5B
$1.2M 0.63%
+15,150
New +$1.02M
CMC icon
39
Commercial Metals
CMC
$8.31B
$1.2M 0.63%
+22,731
New +$1.06M
NDAQ icon
40
Nasdaq
NDAQ
$52.9B
$1.2M 0.63%
+24,012
New +$1.3M
NJR icon
41
New Jersey Resources
NJR
$5.58B
$1.2M 0.63%
+25,359
New +$1.28M
PNC icon
42
PNC Financial Services
PNC
$101B
$1.2M 0.63%
+9,501
New +$1.16M
CNC icon
43
Centene
CNC
$32.5B
$1.2M 0.63%
+17,730
New +$1.18M
DD icon
44
DuPont de Nemours
DD
$19.2B
$1.2M 0.63%
+13,336
New +$1.15M
LBTYA icon
45
Liberty Global Class A
LBTYA
$3.6B
$1.2M 0.63%
+70,941
New +$1.26M
MA icon
46
Mastercard
MA
$493B
$1.2M 0.63%
+3,042
New +$1.14M
TROW icon
47
T. Rowe Price
TROW
$24.3B
$1.2M 0.63%
+10,680
New +$1.17M
VRSK icon
48
Verisk Analytics
VRSK
$25B
$1.2M 0.63%
+5,292
New +$1.11M
RMD icon
49
ResMed
RMD
$30.7B
$1.19M 0.63%
+5,463
New +$1.22M
UGI icon
50
UGI
UGI
$7.33B
$1.19M 0.63%
+44,262
New +$1.34M

Similar funds

Neo Ivy Capital Management's Q2 2023 Portfolio in Review

Q2 2023 is the first quarter with a 13F filing on record for Neo Ivy Capital Management, which disclosed 278 positions worth $190M. Its ten largest holdings account for 17% of the portfolio.

Its largest position is Humana: 7,737 shares worth $3.46M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Healthcare and Industrials.

  • Neo Ivy Capital Management's largest Q2 2023 buy was Humana: 7,737 shares worth $3.46M.
  • Neo Ivy Capital Management's ten largest holdings make up 17% of its $190M portfolio in Q2 2023.
  • Neo Ivy Capital Management disclosed 278 positions in Q2 2023, its first 13F filing on record.

Based on Neo Ivy Capital Management's 13F filing for Q2 2023, filed 16 Aug 2023.